# EDGAR Filing Document

**Accession Number:** 0001109138
**File Stem:** 0001178913-26-003236
**Filing Date:** 2026-6
**Character Count:** 35790
**Document Hash:** 687160410d4577d8620ff255eef28af0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-26-003236.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 0001178913-26-003236

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 13

**FILED AS OF DATE**: 20260617

**DATE AS OF CHANGE**: 20260617

**EFFECTIVENESS DATE**: 20260617

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CAMTEK LTD
- **CENTRAL INDEX KEY:** 0001109138
- **STANDARD INDUSTRIAL CLASSIFICATION:** OPTICAL INSTRUMENTS & LENSES [3827]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-296849
- **FILM NUMBER:** 261098231

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** INDUSTRIAL ZONE
- **STREET 2:** PO BOX 544
- **CITY:** MIGDAL HAEMEK
- **PROVINCE COUNTRY:** L3
- **BUSINESS PHONE:** 972-4-604-8100

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** INDUSTRIAL ZONE
- **STREET 2:** PO BOX 544
- **CITY:** MIGDAL HAEMEK
- **PROVINCE COUNTRY:** L3

As filed with the Securities and Exchange Commission on June 17, 2026

Registration No. 333-__________

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

___________

**FORM S-8**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

___________

**CAMTEK LTD.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Israel**<br>(State or other jurisdiction<br>of incorporation or organization)<br>| **Not Applicable**<br>(I.R.S. Employer Identification No.)<br>|

---

**Ramat Gavriel Industrial Zone**

**P.O. Box 544**

**Migdal Ha'Emek** **2309407, Israel**

**(972) 4-604-8100**

(Address of Principal Executive Offices) (Zip Code)

___________

**Camtek Ltd. 2018 Share Incentive Plan**

(Full title of the plan)

___________

**Camtek USA, Inc.**

**48389 Fremont Blvd., Ste. 112**

**Fremont, CA 94538**

(Name and address of agent for service)

**(510) 624-9905**

(Telephone number, including area code, of agent for service)

Copies of all communications, including all communications sent to the agent for service, should be sent to:

---

| | |
|:---|:---|
| **Todd E. Lenson, Esq.**<br>**Herbert Smith Freehills Kramer (US) LLP**<br>**1177 Avenue of the Americas** <br>**New York, New York 10036** <br>**Tel: 212-715-9216**<br>**Fax: 212-715-8216**<br>| **Maya Koubi Bara-nes, Adv.** <br> **Jonathan Neumann, Adv.** <br> **Shibolet & Co. Law Firm**<br>**Tou Towers, 4 Yitzhak Sadeh Street,**<br>**Tel-Aviv 6777504, Israel**<br>**Tel: + 972-3-307-5000**<br>**Fax: + 972-3-777-8444**<br>|

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒ Accelerated Filer ☐ <br> Non-accelerated filer ☐ Smaller reporting company ☐ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financing accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**EXPLANATORY NOTE**

This Registration Statement relates to an additional 1,000,000 Ordinary Shares, par value NIS 0.01 per share (the "Ordinary Shares") of Camtek Ltd. (the "Registrant") that are being issued and sold, or may be issued and sold, upon settlement of restricted share units or exercise of options granted by the Registrant to participants in the Camtek Ltd. 2018 Share Incentive Plan (the "2018 Plan").

Reference is made to the Registrant's Registration Statement on Form S-8 filed with the Securities and Exchange Commission (the "Commission") on October 22, 2018 (Registration No. 333-227931) (the "2018 Registration Statement") and on May 27, 2020 (Registration No. 333-238705) (the "2020 Registration Statement"), pursuant to which a total of 3,000,000 Ordinary Shares issuable under the 2018 Plan were registered under the Securities Act. Pursuant to General Instruction E to Form S-8, the contents of the 2018 Registration Statement and 2020 Registration Statement are hereby incorporated by reference in their entirety, except as otherwise updated or modified by this Registration Statement.

**PART II**

**Information Required in the Registration Statement**

Item 3. <u>Incorporation of Documents by Reference</u>

The Registrant hereby incorporates by reference in this Registration Statement the following documents:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the Registrant's Annual Report on [Form 20-F](https://www.sec.gov/ix?doc=/Archives/edgar/data/1109138/000117891326001561/zk2634678.htm) for the fiscal year ended December 31, 2025 filed with the Commission on March 19, 2026 (File No. 000-30664);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the Registrant's Reports of Foreign Issuer on Form 6-K, as filed with the Commission on [February 10, 2026](https://www.sec.gov/Archives/edgar/data/1109138/000117891326000398/zk2634331.htm), [March 30, 2026](https://www.sec.gov/Archives/edgar/data/1109138/000117891326001836/zk2634993.htm), [April 14, 2026](https://www.sec.gov/Archives/edgar/data/1109138/000117891326002105/zk2635069.htm), [May 12, 2026](https://www.sec.gov/Archives/edgar/data/1109138/000117891326002569/zk2635285.htm) and [June 02, 2026](https://www.sec.gov/Archives/edgar/data/1109138/000117891326003033/zk2635474.htm); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the description of the Registrant's Ordinary Shares contained in the Registrant's Registration Statement on Form 8-A filed with the Commission pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), on August 4, 2000, including any amendment or report filed for the purpose of updating such description, including the description of the Registrant's Ordinary Shares contained in [Exhibit 2.1](https://www.sec.gov/Archives/edgar/data/1109138/000117891325000945/exhibit_2-1.htm) to the Registrant's Annual Report on Form 20-F for the fiscal year ended December 31, 2025, filed with the Commission on March 19, 2025, and any amendment or report filed for the purpose of further updating such description.

All documents subsequently filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, and all Reports of Foreign Private Issuer on Form 6-K submitted by the Registrant to the Commission during such period, or portions thereof that are identified in such forms as being incorporated into this Registration Statement, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents. Any document, or any statement contained in a document, incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a document or statement contained herein, or in any other subsequently filed document that also is deemed to be incorporated by reference herein, modifies or supersedes such document or statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement. Subject to the foregoing, all information appearing in this Registration Statement is qualified in its entirety by the information appearing in the documents incorporated by reference.

Item 6. <u>Indemnification of Directors and Officers</u>

Pursuant to the Israeli Companies Law, 5759-1999 (the "Companies Law") and the Israeli Securities Law, 5728-1968 (the "Securities Law"), the Israeli Securities Authority is authorized to impose administrative sanctions, including monetary fines, against companies like ours and their officers and directors, for certain violations of the Securities Law or the Companies Law. The Company's Law provides that companies like the Registrant may indemnify their officers and directors and purchase an insurance policy to cover certain liabilities, if provisions for that purpose are included in their articles of association.

Registrant's Articles of Association (the "Articles") allows it to indemnify and insure its Office Holders (as such term is defined in the Companies Law) to the fullest extent permitted by law.

 *Office Holders' Exemption*

Under the Companies Law, and provided that the company's articles of association allow it to do so, an Israeli company may exempt in advance an Office Holder from his or her liability to the company, in whole or in part, for a breach of his or her duty of care (except in connection with distributions). Exemption from liability for a breach of duty of loyalty is not allowed. The Articles allows the Registrant to exempt its Office Holders to the fullest extent permitted by law.

 *Office Holders' Insurance* 

The Articles provide that, subject to the provisions of the Companies Law, Registrant may enter into a contract for the insurance of all or part of the liability imposed on Office Holders in respect of an act performed by him or her in his or her capacity as an Office Holder, concerning the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· a breach of his or her duty of care to us or to another person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· a breach of his or her duty of loyalty to the Registrant provided that the Office Holder acted in good
faith and had reasonable cause to assume that his or her act would not prejudice our interests; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· a financial liability imposed upon him or her in favor of another person.

Without derogating from the aforementioned, subject to the provisions of the Companies Law and Israel's Securities Law, 5728-1968 (the "Israeli Securities Law"), the Registrant may also enter into a contract to insure an Office Holder for expenses, including reasonable litigation expenses and legal fees, incurred by him or her in relation to an administrative proceeding instituted against such Office Holder or payment required to be made to an injured party pursuant to certain provisions of the Israeli Securities Law.

 *Office Holder's Indemnification* 

The Articles provide that, subject to the provisions of the Companies Law and the Israeli Securities Law, the Registrant may indemnify any of its Office Holders in respect of an obligation or expense specified below, imposed on or incurred by the Office Holder in respect of an act performed in his capacity as an Office Holder, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· a financial liability imposed on him or her in favor of another person by any judgment, including a settlement
or an arbitration award approved by a court;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reasonable litigation expenses, including attorney's fees, incurred by the Office Holder as a result
of an investigation or proceeding instituted against him by a competent authority which concluded without the filing of an indictment
against him and without the imposition of any financial liability in lieu of criminal proceedings, or which concluded without the filing
of an indictment against him but with the imposition of a financial liability in lieu of criminal proceedings concerning a criminal offense
that does not require proof of criminal intent or in connection with a financial sanction (the phrases "proceeding concluded without
the filing of an indictment" and "financial liability in lieu of criminal proceeding" shall have the meaning ascribed
to such phrases in section 260(a)(1a) of the Companies Law);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reasonable litigation expenses, including attorneys' fees, expended by an Office Holder or charged
to the Office Holder by a court, in a proceeding instituted against the Office Holder by the Company or on its behalf or by another person,
or in a criminal charge from which the Office Holder was acquitted, or in a criminal proceeding in which the Office Holder was convicted
of an offense that does not require proof of criminal intent; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· expenses, including reasonable litigation expenses and legal fees, incurred by an Office Holder in relation
to an administrative proceeding instituted against such Office Holder, or payment required to be made to an injured party, pursuant to
certain provisions of the Israeli Securities Law.

Registrant may undertake to indemnify an Office Holder as aforesaid, (a) prospectively, provided that, in respect of the first act (financial liability) the undertaking is limited to events which in the opinion of the board of directors are foreseeable in light of the Registrant's actual operations when the undertaking to indemnify is given, and to an amount or criteria set by the board of directors as reasonable under the circumstances, and further provided that such events and amount or criteria are set forth in the undertaking to indemnify, and (b) retroactively; provided, however, that the total aggregate indemnification amount that the Registrant shall be obligated to pay to all of its Office Holders, for all matters and circumstances described above, shall not exceed an amount equal to twenty five percent (25%) of the shareholders' equity at the time of the indemnification.

*Limitations on Insurance and Indemnification*

The Companies Law provides that a company may not insure, exempt or indemnify an Office Holder for any breach of his or her liability arising from any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a breach by the Office Holder of his or her duty of loyalty, except that the company may enter into an
insurance contract or indemnify an Office Holder if the Office Holder acted in good faith and had a reasonable basis to believe that the
act would not prejudice the company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a breach by the Office Holder of his or her duty of care if such breach was intentional or reckless, but
unless such breach was solely negligent;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any act or omission done with the intent to derive an illegal personal benefit; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any fine, civil fine, financial sanction or monetary settlement in lieu of criminal proceedings imposed
on such Office Holder.

Under the Companies Law, exemption and indemnification of, and procurement of insurance coverage for, Office Holders, must be approved by the company's compensation committee and board of directors and, with respect to the CEO and to an Office Holder who is a director also by company's shareholders. However, according to regulations promulgated under the Companies Law with respect to relief in approval of certain related party transactions (the "Relief Regulations"), shareholders' approval for the procurement of directors' insurance is not required if the insurance policy is approved by the compensation committee and (i) the terms of such policy are within the framework for insurance coverage as approved by our shareholders and set forth in our compensation policy; (ii) the premium paid under the insurance policy is at fair market value; and (iii) the insurance policy does not and may not have a substantial effect on the Company's profitability, assets or obligations. Further, as the Registrant's insurance coverage includes Office Holders who are controlling shareholders, in accordance with the Relief Regulations, shareholders' approval may be waived, if the compensation committee approves that the terms of the insurance policy are identical with respect to all Office Holders, including the controlling shareholders.

Indemnification letters, covering exemption from, indemnification and insurance of those liabilities imposed under the Companies Law and the Israeli Securities Law discussed above, were granted to each of the Registrant's present Office Holders and were approved for future Office Holders. Hence, the Registrant indemnifies its Office Holders to the fullest extent permitted under the Companies Law.

The Registrant currently holds directors' and officers' liability insurance policy for the benefit of its Office Holders, including its directors. This policy was approved by the Registrant's compensation committee on May 7, 2024, and is effective until October 31, 2025.

Insofar as indemnification for liabilities arising under the United States Securities Act of 1933, as amended, may be permitted to the Registrant's directors, officers and controlling persons, the Registrant have been advised that, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

Item 8. <u>Exhibits</u>

<u>The following is a list of exhibits filed as part of this Registration Statement and incorporated herein:</u>

---

| | |
|:---|:---|
| <u>Exhibit Number</u> | <u>Description</u> |
| [4.1](https://www.sec.gov/Archives/edgar/data/1109138/000091205700032839/ex-3_1.txt) | [Memorandum of Association of the Registrant (incorporated herein by reference to Exhibit 3.1 to Amendment No. 1 to the Registrant's Registration Statement on Form F-1, File No. 333-12292, filed with the Commission on July 21, 2000).](https://www.sec.gov/Archives/edgar/data/1109138/000091205700032839/ex-3_1.txt) |
| [4.2](http://www.sec.gov/Archives/edgar/data/1109138/000117891325000945/exhibit_1-2.htm) | [Articles of Association of the Registrant, as amended on April 29, 2025 (incorporated herein by reference to Exhibit 1.2 to the Registrant's Annual Report on Form 20-F, File No. 000-30664, filed with the Commission on March 19, 2025).](https://www.sec.gov/Archives/edgar/data/1109138/000117891325000945/exhibit_1-2.htm) |
| [4.3](https://www.sec.gov/Archives/edgar/data/1109138/000117891318002697/exhibit_4-3.htm) | [Camtek Ltd. 2018 Share Incentive Plan (incorporated herein by reference to Exhibit 4.3 to the Registrant's Registration Statement on Form S-8, File No. 333-227931, filed with the Commission on October 22, 2018).](https://www.sec.gov/Archives/edgar/data/1109138/000117891318002697/exhibit_4-3.htm) |
| [5.1\*](exhibit_5-1.htm) | [Opinion of Shibolet & Co. Law Firm.](exhibit_5-1.htm) |
| [23.1\*](exhibit_23-1.htm) | [Consent of Somekh Chaikin, Independent Registered Public Accounting Firm, a member firm of KPMG International.](exhibit_23-1.htm) |
| [23.2\*](exhibit_5-1.htm) | [Consent of Shibolet & Co. Law Firm (included in Exhibit 5.1).](exhibit_5-1.htm) |
| [24.1\*](#p_oa) | [Power of Attorney (included in the signature page to this Registration Statement).](#p_oa) |
| [107\*](exhibit_107.htm) | [Filing Fee Table](exhibit_107.htm) |

---

\*Filed herewith

Item 9. <u>Undertakings</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The undersigned Registrant hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this
Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to reflect in the prospectus of any facts or events arising after the effective date of the registration
statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price
set forth in the "Calculation of Registration Fee Tables" or "Calculation of Registration Fee" table, as applicable,
in the effective registration statement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) to include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement;

*provided, however,* that paragraphs (1)(i) and (1)(ii) do not apply if the information required to be included in a post-effective amendment by those clauses is contained in periodic reports filed by the Registrant pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial *bona fide* offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment of any of the securities being registered
which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act of 1933, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of
the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial *bona fide* offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to
directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been
advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the
Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by
the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or controlling person of the Registrant in connection with the securities
being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit
to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act
and will be governed by the final adjudication of such issue.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Migdal Ha'Emek, Israel, on June 17, 2026.

---

| | |
|:---|:---|
| **CAMTEK LTD.** | **CAMTEK LTD.** |
| By: | /s/ Rafi Amit |
| Name: | Rafi Amit |
| Title: | Chief Executive Officer |

---

**<u>POWER OF ATTORNEY</u>**

Each person whose signature appears below constitutes and appoints Rafi Amit and Moshe Eisenberg, and each of them acting alone, his true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution in each of them acting alone, for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement of Camtek Ltd., and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting to the attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any or each of them or their substitute may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| <u>/s/ Rafi Amit</u><br>Rafi Amit<br>| Chief Executive Officer and Director | June 17, 2026 |
| <u>/s/ Moshe Eisenberg</u><br>Moshe Eisenberg<br>| Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | June 17, 2026 |
| <u>/s/ Lior Aviram</u><br><u>Lior Aviram</u><br>| Director and Chairman of the Board of Directors | June 17, 2026 |
| <u>/s/ Moty Ben-Arie</u><br>Moty Ben-Arie<br>| Director | June 17, 2026 |
| <u>/s/ Yotam Stern</u><br>Yotam Stern<br>| Director | June 17, 2026 |
| <u>/s/ Yael Andorn</u><br>Yael Andorn<br>| Director | June 17, 2026 |
| <u>/s/ Yossi Shacham-Diamand</u><br>Yossi Shacham-Diamand<br>| Director | June 17, 2026 |
| <u>/s/ Leo Huang</u><br>Leo Huang<br>| Director | June 17, 2026 |
| <u>/s/ I-Shih Tseng</u><br>I-Shih Tseng<br>| Director | June 17, 2026 |
| <u>/s/ Orit Stav</u><br>Orit Stav<br>| Director | June 17, 2026 |

---

Pursuant to the requirements of Section 6(a) of the Securities Act, the undersigned has signed the Registration Statement solely in the capacity of the duly authorized representative of the Registrant in the United States on the date indicated.

---

| | | |
|:---|:---|:---|
| AUTHORIZED REPRESENTATIVE IN THE UNITED STATES<br>**Camtek USA, Inc.**<br>1815 NW 169th Place<br>Suite 1080<br>Beaverton, OR 97006 | AUTHORIZED REPRESENTATIVE IN THE UNITED STATES<br>**Camtek USA, Inc.**<br>1815 NW 169th Place<br>Suite 1080<br>Beaverton, OR 97006 | |
| <u>/s/ Rafi Amit</u><br>Rafi Amit<br>| Chief Executive Officer and Director | June 17, 2026 |

---

## Exhibit 5.1

**<u>Exhibit 5.1</u>**

Tel Aviv, June 17, 2026

Ref: C-59-10

Camtek Ltd.

P.O. Box 544

Migdal Haemek, 2309407<br> Israel

**<u>Re: Camtek Ltd. – Registration Statement on Form S-8</u>**

Ladies and Gentlemen:

We refer to the registration statement on Form S-8 (the "Registration Statement"), to be filed by Camtek Ltd., a Company organized under the laws of the State of Israel (the "Company"), with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended (the "Act"), relating to the registration of 1,000,000 of the Company's Ordinary Shares, nominal value NIS 0.01 each (the "Shares"), authorized for issuance pursuant to the Company's 2018 Share Incentive Plan, including its sub-plans (the "2018 Plan").

This opinion is being furnished in accordance with the requirements of Item 8 of Form S-8 and Item 601(b)(5)(i) of Regulation S-K.

In our capacity as the Company's Israeli counsel in connection with the registration of the Shares pursuant to the Registration Statement, we have examined copies of the Company's Articles of Association, as amended, the 2018 Plan, protocols of meetings of the board of directors of the Company with respect to the reservation of the Shares for issuance under the 2018 Plan and other corporate records, instruments and documents we have considered necessary or appropriate for the purpose of this opinion, which were presented to us by the Company, and such matters of Israeli law we have considered necessary or appropriate for the purpose of rendering this opinion. We have assumed that the Company presented to us all such protocols and documents relating to or having any bearing on the 2018 Plan.

In our examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the correctness and completeness of certificates of public officials and the representations set forth therein, the authenticity of all documents submitted to us as originals and the conformity to authentic original documents of all documents submitted to us as copies. We have assumed the same to have been properly given and to be accurate and we have assumed the truth of all facts communicated to us by the Company. We have also assumed that all protocols of meetings of the Company's Board of Directors which have been provided to us are true and accurate and have been properly prepared in accordance with the Company's incorporation documents and all applicable laws. We have also assumed that each individual grant under the 2018 Plan to be made after the date hereof will be duly authorized by all necessary corporate action in accordance with the Israeli Companies Law, 5759-1999, as amended, and regulations promulgated thereunder.

Based upon and subject to the foregoing, we are of the opinion that the Shares being registered pursuant to this Registration Statement have been duly and validly authorized for registration under the Registration Statement, and if, and when, issued and paid for (where applicable) upon the exercise, conversion or settlement of awards pursuant to the terms and conditions of the 2018 Plan, such Shares will be validly issued, fully paid and nonassessable.

We are members of the Israeli Bar and we are opining herein as to the effect on the subject matter only of the internal laws of the State of Israel, and we express no opinion with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction.

This opinion letter is rendered as of the date hereof and we disclaim any obligation to advise you of facts, circumstances, events or developments, including, without limitation, in the law, which hereafter may be brought to our attention and which may alter, affect or modify the opinion expressed herein. Our opinion is expressly limited to the matters set forth above and we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company, the 2018 Plan or the Shares.

We consent to the filing of this opinion as an exhibit to the Registration Statement. This consent is not to be construed as an admission that we are a party whose consent is required to be filed with the Registration Statement under Section 7 of the Act or the rules and regulations promulgated thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Very truly yours,<br><u>/s/ Shibolet & Co. Law Firm</u><br>Shibolet & Co. Law Firm<br>

## Exhibit 23.1

**<u>Exhibit 23.1</u>**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use of our report dated March 19, 2026, with respect to the consolidated financial statements of Camtek Ltd., and the effectiveness of internal control over financial reporting, incorporated herein by reference.

<u>/s/ Somekh Chaikin</u>

A Member firm of KPMG International

Tel Aviv, Israel

June 17, 2026

## Ex-Filing

?xml version='1.0' encoding='ASCII'? Filing Fee Exhibit

**Ex-Filing Fees**

**CALCULATION OF FILING FEE TABLES**

**S-8**

**CAMTEK LTD**

**Table 1: Newly Registered Securities**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Notes** | **Fee Calculation<br> Rule** | **Amount Registered** | **Proposed Maximum Offering<br> Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | Ordinary Shares, nominal (par) value NIS 0.01 per share ("Ordinary Shares") | (1) | Other | 1000000 | $170.39 | $170390000.00 | 0.0001381 | $23530.86 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | $170390000.00 |  | 23530.86 |
| Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: |  |  | 0.00 |
| Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: |  |  | $23530.86 |

---

**__________________________________________ Offering Note(s)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) a. Represents 1,000,000 Ordinary Shares issuable under the Camtek Ltd. 2018 Share Incentive Plan (the "2018 Plan"), over and above the number of Ordinary Shares issuable under the 2018 Plan that were previously registered under the Securities Act. b. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall also cover any additional Ordinary Shares that may become issuable under the 2018 Plan, by reason of any share dividend, share split, recapitalization or other similar transaction effected without the Registrant's receipt of consideration that increases the number of Ordinary Shares of the Registrant. c. Pursuant to Rule 457(c) and 457(h) of the Securities Act, the proposed maximum offering price per Ordinary Share and the proposed maximum aggregate offering price are based on the average of the high and low prices per share of the Ordinary Shares of the Registrant as reported by the NASDAQ Global Market on June 10, 2026, which is within five (5) business days prior to the date of this Registration Statement.